IHRA is a single touchpoint, easy to use, portable solution for preventive healthcare screenings. It provides individual comorbidity evaluation report for chronic diseases like Type 2 Diabetes, Hypertension, and Dyslipidemia. Our software uses an IR radiation-based, passive video as input, which is free of any harmful radiation and provides a risk evaluation score as IMRI (Individual Morbidity Risk Index) on a scale of ten (where zero is normal and 10 is high risk) for Type 2 diabetes, Hypertension and Dyslipidemia. We further categorize the risk to very low, low, medium, and high based on the score. Our technology is developed using computer vision, signal processing, and machine learning models. Our algorithms use thermal pattern values to calculate the observed variance related to atherosclerosis, arteriosclerosis, and hemodynamics, which will work as a biomarker to identify the condition and its severity. Our artificial intelligence-models will ensure that our solution provides accurate results and is self-trained for precision diagnosis. Our risk evaluation for each of these diseases includes pre-diagnosis and disease monitoring. This medically reviewed, non-invasive method of identifying risk index will help everyone to know their risk of developing a chronic disease and provides an opportunity to take precautionary steps to delay the onset of the symptoms or to avoid developing the condition itself. While this is first-of-its-kind imaging is a new diagnostic modality for diagnosing Type 2 Diabetes, Hypertension and Dyslipidemia, our report is not a replacement for existing medical treatment but is an adjunct modality. If you are a healthcare facility or a diagnostic facility or an NGO conducting a camp or a corporate interested in improving your employees' health, IHRA is your solution!